top of page
gradientForSurfBreak.png

Item List

Businesswire
FDA Grants Second Breakthrough Device Designation for Carlsmed Technology

Carlsmed announced today that the FDA granted Breakthrough Device designation for its aprevo® technology for treatment of patients with cervical spine disease. This is Carlsmed’s second Breakthrough Device designation, complementing the company’s family of lumbar patient-specific interbody fusion devices for anterior, lateral, and transforaminal approaches.

Recent Posts

Portfolio Company

Carlsmed.png

Ready. Set. Food! and ObvioHealth Launch Innovative Trial to Correlate Infant Fo ...

PR Newswire

Portfolio Company

Carlsmed.png

Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Emp ...

Yahoo Finance

Portfolio Company

Carlsmed.png

xCures: Empowering Healthcare Researchers To Deeply Understand Each Patient’s Me ...

Pulse 2.0

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page